<DOC>
	<DOCNO>NCT00223210</DOCNO>
	<brief_summary>The purpose study determine quetiapine add-on therapy associate decrease cocaine use crave great improvement mood .</brief_summary>
	<brief_title>An Add-On Trial Quetiapine Patients With Bipolar Disorder Cocaine Dependence</brief_title>
	<detailed_description>One Hundred ( 100 ) outpatient diagnosis bipolar I disorder cocaine abuse/dependence , establish structure clinical interview confirm psychiatrist , participate . Eligible participant give physical exam , include eye exam ophthalmoscope rule serious medical illness cataract . Additionally , medical psychiatric history baseline lab , include CBC liver panel obtain . Blood drawn routine laboratory analysis include complete blood count ( CBC ) SMA-20 baseline exit . Women childbearing potential give urine pregnancy test . Baseline measure psychiatric symptom assess Hamilton Rating Scale Depression HRSD , Young Mania Rating Scale ( YMRS ) , Inventory Depression Symptomatology-Self-Report 30-item version ( IDS-SR30 ) , Psychobiology Recovery Depression III - Somatic Symptom Scale ( PRD-III ) . Cocaine crave assessed Cocaine Craving Questionnaire ( CCQ ) . Drug use assess self-report , Addiction Severity Index ( ASI ) urine drug screen ( UDS ) . Two UDSs perform baseline . Cocaine use past week ( dollar amount spent/week day used/week ) assess patient self-report . Use crave substance ( benzodiazepine , barbiturate , alcohol , opiates , phencyclidine , cannabis ) also assess self-report dollar amount day use past week , UDSs , 100-mm single item visual analog crave scale . Side effect assess Abnormal Involuntary Movement Scale ( AIMS ) , Simpson-Angus Scale ( SAS ) , Barnes Akathesia Rating Scale ( BARS ) . Subjects randomize titrated 400 mg/day additional flexible titration time maximum 800 mg/day Quetiapine identical appear placebo add-on therapy double- blind fashion 12 week . At weekly assessment subject evaluate HRSD17 , IDS-R30 , YMRS , CCQ , UDS , receive upward titration study drug . The ASI repeat every four week . Further , participant return one additional time week UDS . At end study unblinded psychiatrist provide standard open label treatment Quetiapine participant transfer back usual treatment facility . Follow care arrangement make participant near completion study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Bipolar Disorder , type I ; Cocaine Dependence use past 7 day ; Currently take mood stabilizer ; Meets criteria hypomanic manic episode Bipolar Disorder , type II , NOS ; Cyclothymia ; Other substance dependence ; Diabetes ; Initiated therapy past 2 week ; History cataracts likely cataract ; Current active suicidal homicidal ideation ; Life threaten medical condition ; Mental retardation , dementia severe cognitive impairment ; Pregnant nursing womenon ; antipsychotic within 7 day begin Quetiapine therapy initiate antidepressant mood stabilizer psychotherapy within past two week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>cocaine dependence</keyword>
	<keyword>quetiapine</keyword>
</DOC>